Moderna Curbing Investments in Vaccine Trials Due To US Backlash, CEO Says
An anonymous reader shares a report: Moderna does not plan to invest in new late-stage vaccine trials because of growing opposition to immunizations from U.S. officials, CEO Stephane Bancel said in an interview with Bloomberg TV on Thursday. “You cannot make a return on investment if you don’t have access to the U.S. market, … ⌘ Read more